BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3630357)

  • 1. [Study of the DNA-binding capacity of the blood serum in evaluating the activity of systemic lupus erythematosus and scleroderma].
    Glavinskaia TA; Rezaĭkina AV; Komarova VD
    Vestn Dermatol Venerol; 1987; (6):20-2. PubMed ID: 3630357
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear autoantibodies in systemic diseases].
    Butov IuS
    Vestn Dermatol Venerol; 1980 Nov; (11):17-22. PubMed ID: 7003977
    [No Abstract]   [Full Text] [Related]  

  • 3. Circumscribed scleroderma with immunologic evidence of systemic lupus erythematosus.
    Mitchell AJ; Rusin LJ; Diaz LA
    Arch Dermatol; 1980 Jan; 116(1):69-73. PubMed ID: 6153258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Humoral and cellular immunity indices in lupus erythematosus and scleroderma].
    Butov IuS; Skripkin IuK; Koshevenko IuN
    Vestn Dermatol Venerol; 1978 Apr; (4):7-11. PubMed ID: 77599
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
    Hayakawa I; Hasegawa M; Takehara K; Sato S
    Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
    Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
    Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
    [No Abstract]   [Full Text] [Related]  

  • 7. Idiotypic/antiidiotypic interactions in systemic lupus erythematosus: demonstration of oscillating levels of anti-DNA autoantibodies and reciprocal antiidiotypic activity in a single patient.
    Zouali M; Eyquem A
    Ann Immunol (Paris); 1983; 134C(3):377-91. PubMed ID: 6625532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of DNA-binding activity of blood serum in systemic lupus erythematosus, rheumatoid arthritis and crossing syndromes].
    Matveĭkov GP; Podgorodnichenko VK; Koshelev VK; Nazarov IuM
    Ter Arkh; 1976; 48(11):36-40. PubMed ID: 1021891
    [No Abstract]   [Full Text] [Related]  

  • 9. Hybridoma anti-DNA autoantibodies from patients with rheumatoid arthritis and systemic lupus erythematosus demonstrate similar nucleic acid binding characteristics.
    Rauch J; Massicotte H; Tannenbaum H
    J Immunol; 1985 Jan; 134(1):180-6. PubMed ID: 3964813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levamisole in the treatment of systemic lupus erythematosus--preliminary results.
    Feng PH; Oon CJ; Yo SL; Lau YK
    Singapore Med J; 1978 Sep; 19(3):120-4. PubMed ID: 751195
    [No Abstract]   [Full Text] [Related]  

  • 11. [HLA and ceruloplasmin phenotypes in lupus erythematosus and circumscribed scleroderma].
    Glavinskaia TA; Rezaĭkina AV; Komarova VD; Sidorova TI
    Vestn Dermatol Venerol; 1989; (6):9-13. PubMed ID: 2588797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recent aspects of selected autoantibodies in patients with systemic lupus erythematosus and their clinical relevance. I. DNA-binding autoantibodies].
    Wollina U
    Allerg Immunol (Leipz); 1983; 29(3):127-34. PubMed ID: 6227213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibodies cross-reactive with DNA and cardiolipin in patients with systemic lupus erythematosus.
    Koike T; Tomioka H; Kumagai A
    Clin Exp Immunol; 1982 Nov; 50(2):298-302. PubMed ID: 7151328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of serum IgG, IgM, and anti-native-DNA antibodies with renal and clinical indexes of activity in systemic lupus erythematosus.
    Feldman MD; Huston DP; Karsh J; Balow JE; Klima E; Steinberg AD
    J Rheumatol; 1982; 9(1):52-8. PubMed ID: 7045362
    [No Abstract]   [Full Text] [Related]  

  • 17. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns.
    Matsuki Y; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Nakamura H
    J Clin Apher; 1996; 11(1):30-5. PubMed ID: 8722720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinucleosome antibody is a major autoantibody in localized scleroderma.
    Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K
    Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies in patients with oral lupus erythematosus, lichen planus and leukoplakia. An aid in diagnosis.
    Schiødt M; Permin H; Wiik A; Manthorpe R
    Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):59-63. PubMed ID: 6603096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of bemetil on the production of DNA antibodies in patients with systemic lupus erythematosus].
    Lisitsyna TA; Durnev AD; Ivanova MM; Speranskiĭ AI; Seredenin SB; Nasonova VA
    Eksp Klin Farmakol; 1999; 62(5):38-41. PubMed ID: 10572751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.